Recurrent infections, Recurrent respiratory infections, Recurrent skin infections, Short stature

abnormal renal glomerulus morphology, abnormal splenocyte physiology, ameloblast degeneration, circling, decreased CD4-positive, alpha beta T cell number, decreased catalase level, decreased circulating interleukin-1 beta level, decreased erythrocyte cell number, decreased hematocrit, decreased hemoglobin content, decreased hepatocyte proliferation, decreased interleukin-1 beta secretion, decreased liver weight, decreased tumor necrosis factor secretion, decreased urine creatinine level, embryo phenotype, enlarged lung, enlarged lymph nodes, glomerular crescent, hematopoietic system phenotype, homeostasis/metabolism phenotype, impaired liver regeneration, increased acute inflammation, increased anti-double stranded DNA antibody level, increased anti-nuclear antigen antibody level, increased cellular sensitivity to hydrogen peroxide, increased cerebral infarct size, increased circulating alanine transaminase level, increased circulating interleukin-1 beta level, increased circulating interleukin-6 level, increased circulating tumor necrosis factor level, increased fibroblast apoptosis, increased hepatocyte apoptosis, increased incidence of tumors by chemical induction, increased kidney cell proliferation, increased lactate dehydrogenase level, increased lung weight, increased macrophage cell number, increased mesangial cell number, increased number of Howell-Jolly bodies, increased physiological sensitivity to xenobiotic, increased sensitivity to xenobiotic induced morbidity/mortality, increased spleen weight, increased splenocyte apoptosis, increased stomach tumor incidence, increased susceptibility to experimental autoimmune uveoretinitis, increased susceptibility to induced colitis, increased susceptibility to injury, increased susceptibility to ischemic brain injury, lung hemorrhage, macrovesicular hepatic steatosis, no abnormal phenotype detected, oxidative stress, premature death, spongiform encephalopathy